Rhythm Pharmaceuticals to Provide an Update on Genetic Sequencing Efforts and Expansion of Phase 2 Basket Study with Four Additional Rare MC4R Pathway-driven Disorders September 9, 2019 - NASDAQ Companies 0 » View More News for September 09, 2019
